Camlin Fine Sciences Ltd
₹ 135
12.89%
05 Jun
- close price
About
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
Key Points
- Market Cap ₹ 2,595 Cr.
- Current Price ₹ 135
- High / Low ₹ 335 / 96.2
- Stock P/E
- Book Value ₹ 48.4
- Dividend Yield 0.00 %
- ROCE 2.14 %
- ROE -1.86 %
- Face Value ₹ 1.00
Pros
Cons
- Stock is trading at 2.79 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.91% over past five years.
- Company has a low return on equity of -2.00% over last 3 years.
- Company has high debtors of 207 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Commodities BSE 1000
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 431 | 412 | 325 | 403 | 548 | 580 | 600 | 686 | 789 | 773 | 886 | 838 | |
| 370 | 344 | 300 | 395 | 515 | 517 | 534 | 605 | 656 | 738 | 807 | 790 | |
| Operating Profit | 61 | 68 | 24 | 8 | 33 | 63 | 66 | 80 | 133 | 35 | 80 | 48 |
| OPM % | 14% | 16% | 8% | 2% | 6% | 11% | 11% | 12% | 17% | 5% | 9% | 6% |
| 2 | -1 | 13 | 9 | 14 | 21 | 5 | 19 | 29 | 17 | -75 | 19 | |
| Interest | 21 | 22 | 26 | 26 | 23 | 31 | 36 | 36 | 62 | 62 | 75 | 67 |
| Depreciation | 10 | 10 | 12 | 9 | 9 | 11 | 19 | 27 | 33 | 49 | 53 | 54 |
| Profit before tax | 32 | 35 | 0 | -18 | 14 | 41 | 15 | 36 | 67 | -60 | -123 | -54 |
| Tax % | 19% | 26% | 809% | -22% | 24% | 26% | 45% | 28% | 29% | -14% | -38% | -39% |
| 26 | 26 | -1 | -14 | 11 | 31 | 8 | 26 | 48 | -51 | -76 | -33 | |
| EPS in Rs | 2.40 | 2.37 | -0.07 | -1.04 | 0.79 | 2.26 | 0.58 | 1.47 | 2.70 | -2.73 | -4.06 | -1.72 |
| Dividend Payout % | 17% | 17% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 2% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -191% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -4% |
| 3 Years: | -6% |
| 1 Year: | -49% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 | 19 | 19 |
| Reserves | 88 | 111 | 165 | 319 | 335 | 365 | 452 | 577 | 626 | 699 | 843 | 910 |
| 135 | 159 | 242 | 218 | 313 | 340 | 378 | 461 | 617 | 511 | 458 | 482 | |
| 113 | 102 | 56 | 128 | 120 | 175 | 224 | 293 | 335 | 345 | 309 | 361 | |
| Total Liabilities | 346 | 382 | 474 | 678 | 781 | 891 | 1,067 | 1,346 | 1,594 | 1,572 | 1,629 | 1,772 |
| 63 | 89 | 79 | 72 | 82 | 96 | 294 | 304 | 583 | 577 | 569 | 526 | |
| CWIP | 0 | 1 | 14 | 20 | 68 | 198 | 18 | 207 | 28 | 31 | 9 | 23 |
| Investments | 5 | 7 | 44 | 148 | 69 | 74 | 74 | 82 | 82 | 80 | 102 | 217 |
| 278 | 285 | 337 | 438 | 562 | 523 | 681 | 753 | 901 | 884 | 949 | 1,007 | |
| Total Assets | 346 | 382 | 474 | 678 | 781 | 891 | 1,067 | 1,346 | 1,594 | 1,572 | 1,629 | 1,772 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 51 | -30 | -5 | -45 | 74 | 26 | 47 | 19 | 82 | 22 | 44 | |
| -23 | -49 | -31 | -116 | -3 | -66 | -88 | -172 | -115 | -52 | -88 | -30 | |
| -5 | -1 | 61 | 120 | 65 | -26 | 80 | 129 | 78 | -34 | 101 | -13 | |
| Net Cash Flow | -1 | 0 | 0 | -1 | 17 | -18 | 18 | 3 | -18 | -4 | 35 | 0 |
| Free Cash Flow | 3 | 14 | -36 | -20 | -96 | -41 | -13 | -143 | -113 | 41 | 0 | 17 |
| CFO/OP | 59% | 83% | -94% | -61% | -124% | 119% | 55% | 60% | 19% | 286% | 29% | 93% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 87 | 148 | 192 | 174 | 204 | 224 | 235 | 243 | 232 | 171 | 207 |
| Inventory Days | 118 | 176 | 209 | 138 | 98 | 91 | 127 | 132 | 252 | 210 | 200 | 199 |
| Days Payable | 123 | 119 | 65 | 137 | 95 | 125 | 186 | 196 | 248 | 234 | 203 | 258 |
| Cash Conversion Cycle | 100 | 144 | 291 | 192 | 177 | 170 | 165 | 171 | 246 | 208 | 167 | 147 |
| Working Capital Days | 36 | 21 | 10 | 64 | 78 | 68 | 92 | 102 | 109 | 113 | 94 | 95 |
| ROCE % | 24% | 24% | 7% | 2% | 6% | 11% | 7% | 8% | 11% | 0% | 4% | 2% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consolidated Installed Capacity MTPA |
|
||||||||||
| Number of Employees (Direct) Number |
|||||||||||
| Production Volume - CFS Europe (Diphenol Plant) MT |
|||||||||||
| Production Volume - Standalone (Tarapur & Dombivli) MT |
|||||||||||
| Global Presence (Number of Countries) Countries |
|||||||||||
| Global Market Share - TBHQ & BHA % |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % |
|||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
29 May - Transcript of the Investor Call dated May 26, 2026
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
28 May - Camlin Fine Sciences submitted its Annual Secretarial Compliance Report for year ended March 31, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
27 May - Newspaper Publication - Audited Financial Results for the quarter and year ended 31.03.2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
26 May - Audio recording of May 26, 2026 conference call on audited FY26 results available on company website.
-
Announcement under Regulation 30 (LODR)-Change in Management
26 May - Board approved FY26 audited results, AGM on August 11, 2026, and CFO appointment effective August 18, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Feb 2022TranscriptAI SummaryPPT
-
Jan 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
May 2021TranscriptAI SummaryPPT
-
May 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jun 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Dec 2019TranscriptAI SummaryPPT
-
Dec 2019TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
May 2016TranscriptAI SummaryPPT
Business Verticals